Investigation of the implications of atropisomersim for redaporfin-photodynamic therapy efficacy (Conference Presentation)

Claire Donohoe; Fábio Scharbele; Nuno P. F. Gonçalves; Mariette M. Pereira; Lígia C. Gomes-da-Silva; Luis G. Arnaut

doi:10.1117/12.2525645

14 August 2019 Investigation of the implications of atropisomersim for redaporfin-photodynamic therapy efficacy (Conference Presentation)

Claire Donohoe, Fábio Scharbele, Nuno P. F. Gonçalves, Mariette M. Pereira, Lígia C. Gomes-da-Silva, Luis G. Arnaut

Author Affiliations +

Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 110703Z (2019) https://doi.org/10.1117/12.2525645
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States

Abstract

Atropisomerism is a frequently overlooked source of structural diversity in drug development. Photosensitizer development for photodynamic therapy (PDT) is not an exception. The present work aimed at investigating the efficacy of redaporfin (and precursor porphyrin) atropisomers for use in PDT. Redaporfin is a synthetic sulphonamide fluorinated bacteriochlorin with enhanced photostability, strong absorption at 750 nm and high ROS yields which is currently in clinical trials for head and neck cancer (NCT02070432). This bacteriochlorin and related porphyrin have phenyl-macrocyclic single bonds with hindered rotations that can generate a different spatial distribution of the sulphonamide groups in the meta positions. The present work demonstrated that it is possible to separate the four atropisomers of redaporfin, and related porphyrins and chlorins. They are designated as: α4 when all the sulphonamides of the phenyl groups are on the same side of the macrocycle plane; α3β when three of the sulphonamides are in the same side of the plane and one is on the other side of the plane; α2β2 when two sulphonamide groups are on each side and adjacent to each other and finally, αβαβ when two sulphonamides are on each side but alternate in the positions with respect to the macrocycle. Although the photo and physicochemical properties of the four atropisomers are similar, their therapeutic efficacies are dramatically different: the α4 atropisomer is orders of magnitude more toxic than the less photoactive αβαβ atropoisomer. Similar results were found for bacteriochlorins and porphyrins.

Conference Presentation

Citation Download Citation

Claire Donohoe, Fábio Scharbele, Nuno P. F. Gonçalves, Mariette M. Pereira, Lígia C. Gomes-da-Silva, and Luis G. Arnaut "Investigation of the implications of atropisomersim for redaporfin-photodynamic therapy efficacy (Conference Presentation)", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110703Z (14 August 2019); https://doi.org/10.1117/12.2525645

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

Photodynamic therapy

Absorption

Cancer

Clinical trials

Drug development

Head

Neck

Keywords/Phrases

Search In:

Publication Years